No abstract available
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / genetics*
-
Class I Phosphatidylinositol 3-Kinases
-
Female
-
Humans
-
Mutation*
-
Phosphatidylinositol 3-Kinases / genetics*
-
Receptor, ErbB-2 / antagonists & inhibitors*
Substances
-
Phosphatidylinositol 3-Kinases
-
Class I Phosphatidylinositol 3-Kinases
-
PIK3CA protein, human
-
ERBB2 protein, human
-
Receptor, ErbB-2